Abstract
Fibre‑optic subdermal laser treatments for facial rejuvenation—commonly marketed under the brand name Endolift®—use a thin, single‑use optical micro‑fibre introduced into the superficial hypodermis to deliver 1470‑nm diode laser energy for targeted photothermal tissue remodelling. This "inside‑out" energy delivery is intended to tighten laxity along the jawline, jowls and submental region, while selectively remodelling small fat pads and fibroseptal networks. This review examines the mechanism of action, procedural technique, clinical evidence base, complication profile, and integration with structural jawline filler for comprehensive lower‑face rejuvenation. The evidence base is real but immature, with one RCT and predominantly case series with heterogeneous protocols. Outcomes appear operator‑ and protocol‑dependent, underscoring the importance of governance, training, and parameter discipline.
Key Highlights
1470‑nm Diode Laser
The 1470‑nm wavelength has ideal interaction with water and fat, enabling selective photocoagulation for collagenesis and extracellular matrix remodelling via a 200–600 µm micro‑fibre in the superficial hypodermis.
RCT Evidence (n=96)
The most robust facial study—a randomised controlled trial with 18‑month follow‑up—reported significant improvements on a ptosis scale with only transient erythema (2%) and oedema (3%).
Complication Signals
Real‑world reports describe burns, peripheral neuropathies, infection and steatonecrosis, explicitly linked to poor antisepsis, dosimetry control and temperature monitoring.
Structure + Envelope Model
Optimal lower‑face rejuvenation combines structural jawline filler (mandibular angle, prejowl support) with subdermal laser envelope tightening—volume loss cannot be replaced by skin tightening alone.
Context and Terminology
Endolift® is a brand name, most closely associated with Eufoton's LASEmaR® 1500 (1470‑nm) platform and its proprietary fibre ecosystem, but in clinical conversation "Endolift" is often used generically to describe fibre‑optic interstitial/subdermal diode‑laser tightening and focal lipolysis. This review uses "fibre‑optic subdermal diode‑laser rejuvenation" as the technique descriptor and treats "Endolift" as a commonly recognised label.
The term "endolaser" is inconsistently used internationally. In some markets it may refer to the same subdermal fibre technique but using different wavelengths (notably 980 nm as well as 1470 nm in some Brazilian practice patterns), which matters because tissue interaction, heating profile, and complication risk can change with wavelength and parameter selection.
Scope: lower face rejuvenation (jawline, prejowl region/jowls, and submental/chin‑line definition), with explicit discussion of how this technique complements structural jawline fillers commonly placed at/near the mandibular angle and posterior jawline vectors.
Mechanism of Action: Physics, Wavelength Selection and Fibre Technique
Tissue Optics and Why 1470 nm Is Used
The core mechanism is controlled photothermal energy deposition delivered beneath the epidermis/dermis via a micro‑fibre. The manufacturer describes LASEmaR® 1500's "Effective Pulse Control" as a tool to maximise selective photocoagulation for water and fat, reflecting the clinical intent to target hydrated collagenous septa and small adipose compartments while limiting uncontrolled heat spread.
From a practical physics perspective for clinicians, the important points are:
- Energy is delivered subdermally, so the key constraints are not epidermal melanin absorption (as in many surface lasers) but depth control, dwell time, and local thermal confinement around the fibre tip/track.
- The technique attempts to create micro‑zones of thermal effect in the superficial hypodermis and fibroseptal network, triggering immediate collagen contraction plus longer‑term neocollagenesis over subsequent weeks/months.
- Where fat is a treatment target (submental fullness or focal jowl fat), the goal is micro‑emulsification/lipolysis within very small volumes, not bulk surgical fat removal.
Fibre Type, Emission Geometry and Procedural Micro‑Tunnelling
The fibre platform is not a trivial detail. Eufoton describes single‑use, sterile fibres of 200–600 µm diameter, available in linear or radial emission models, supplied sterile and attached to a reusable power cable immediately pre‑procedure. In practice and in the RCT, the fibre is advanced into the correct plane and then moved in a fan‑like pattern, creating micro‑tunnels oriented along anti‑gravitational vectors.
The RCT provides an unusually clear procedural description: the fibre is inserted into superficial‑middle hypodermis, and once positioned the fibre path is visible via an aiming beam. The operator moves the fibre in a fan‑like manner, delivering energy in retrograde then anterograde fashion to create micro‑tunnels aligned to lifting vectors.
Biological Response: Tightening vs Volume
In a jowl‑focused clinical series (n=9), objective changes were reported in skin elasticity (Cutometer parameters) and in ultrasound‑assessed dermal/epidermal density and thickness, consistent with a remodelling response rather than purely perceptual improvement. Even if reproducible, these should be interpreted as improvements in skin envelope quality and fibroseptal support, not restoration of deep compartmental volume loss.
This distinction matters when counselling patients: tightening can improve the drape and edge definition of the lower face, but it does not recreate youthful skeletal projection or deep fat pad volume.
Procedural Technique and Peri‑Procedural Care
Patient Selection
Evidence‑Aligned Selection Framework
- Mild–moderate skin laxity with early jowling, where patients want improvement without surgery
- Discrete jowl fat prominence where micro‑lipolysis may assist, but not major ptosis or heavy laxity
- Patients able to accept that results may be subtle‑to‑moderate, often evolving over 2–3 months as remodelling progresses
- RCT inclusion: Pinch Test <1.9 mm, graded on a ptosis scale at baseline
Contraindications
- Pregnancy/lactation and significant uncontrolled systemic illness
- Active infection or poor antisepsis environment
- Uncontrolled bleeding risk
- Synthetic material on face/neck such as metallic implants or non‑absorbable filler
- Patient goals requiring predominantly volume restoration or true tissue repositioning (surgical‑level jowl lift)
Anaesthesia and Temperature Monitoring
Safety‑Critical Control
In the RCT, skin surface temperature was not to exceed 40°C, measured via an external thermal sensor. A complications‑focused report explicitly recommends rigorous temperature control—citing infrared thermography systems—because burns and deep thermal injuries were prominent in adverse outcomes. Temperature management should be treated as a safety‑critical control, not an optional extra.
Energy Settings and Dosimetry
| Study | Design | n | Fibre | Energy | Follow‑up |
|---|---|---|---|---|---|
| Longo et al. (2022) | RCT (3 arms) | 96 | 300 µm radial | 500–1400 J (mean 800 J) | 18 months |
| Nilforoushzadeh et al. (2022) | Case series | 9 | 200–300 µm | 600–800 J | 3 months |
| Dias et al. (2023) | Pilot | 10 | 400 µm | 4–8 W continuous | 60 days |
Evidence Base: Outcomes, Satisfaction, Complications
Evidence Quality Overview
Recent syntheses are aligned on a central message: despite increasing popularity, the evidence base is dominated by case series with variable protocols. A scoping review (2025) identified 26 endolaser publications, but only 1 RCT with the remainder primarily case series. A separate systematic review in Lasers in Medical Science (2025) selected only 7 articles from 111 screened and concluded that asserting efficacy and safety is challenging due to high risk of bias and inconsistent parametrisation.
Clinical Outcomes
Key Outcome Data
- RCT (n=96): Significant improvement on ptosis scale; majority shifted from grade 4 to grade 2/1 over 18 months. Erythema 2%, oedema 3%.
- Jowl series (n=9): Cutometer + ultrasound improvements; ~90% "good/very good" patient‑rated improvement; no side effects reported (small n).
- Conference data (n=288): Transient redness 99%, swelling 92%, bruising 62%, paraesthesia 21%, "nerve stupor" 0.35%.
Complications: Risk Factors and Mitigation
Complication Clusters
- Thermal injury: Burns, blistering, fat necrosis/steatonecrosis—correlated with excessive energy density, slow fibre movement, repeated passes in thin areas, absence of thermometry
- Nerve effects: Transient sensory changes to serious neuropathies. Marginal mandibular nerve particularly vulnerable near facial vessel crossings
- Infection: Fibre insertion is invasive; aseptic workflow and single‑use sterile fibres are critical
- Aesthetic: Contour irregularity, prolonged swelling, dyschromia, bruising
Comparison with Other Devices
Microfocused ultrasound (MFU‑V): Non‑invasive; creates microthermal lesions at defined depths including SMAS. RCT data (n=51) shows >1‑point jawline improvement at 6 months. Less capacity for targeted micro‑lipolysis vs subdermal laser.
RF microneedling (RFMN): Controlled study (n=30) with ~95% satisfaction and low downtime. Delivers thermal zones through needle electrodes; tightens but may not provide the same track‑based septal contraction.
Surgical facelift: Most predictable for significant laxity and tissue descent; higher morbidity. Endolift‑type subdermal laser bridges between fully external EBDs and surgery.
Structural Jawline Fillers and Multimodal Rejuvenation
Why Jawline Filler Matters
Lower‑face ageing is not only skin laxity. Consensus guidance states that age‑associated volume loss plays an important role in structural changes and that jawline reshaping by replacing volume has become an "indispensable component" of modern facial rejuvenation. Recommended filler insertion points include the mandibular angle and prejowl sulcus, with additional posterior cheek vectors.
The "Structure + Envelope" Complementarity Model
Structure (fillers): Restore mandibular angle projection, prejowl sulcus support, and jawline continuity using appropriate products and planes.
Envelope (subdermal laser): Tighten the overlying skin and superficial fibroseptal network, and in selected cases reduce small residual fat pads in jowl/submental areas.
"We do not use this as the sole means of lifting jowls; volume loss cannot be replaced just by skin tightening." — Dr Ahmed Haq, Cosmodocs
Sequencing and the "Laser Dissolving Filler" Misconception
For hyaluronic acid fillers, the established corrective approach for overcorrection, asymmetry, lumps/nodules and vascular compromise is hyaluronidase. Energy‑based devices can interact with fillers, but the direction of effect is not reliably "dissolving safely." Evidence suggests RF after HA injection may affect filler integrity, especially if done the same day.
Practical sequencing recommendation: Perform subdermal laser first, allow primary swelling/settling, then place structural filler in deep planes. If filler is already present, consider ultrasound mapping and avoid aggressive heating over superficial filler deposits.
Practice Recommendations (Governance Lens)
- Describe accurately: Endolift is a branded implementation of fibre‑optic subdermal diode laser (often 1470 nm). Counsel patients that the evidence base is developing and heterogeneous.
- Adopt objective documentation: Baseline and follow‑up standardised photographs; where available, 3D imaging or ultrasound; validated scales (Merz jawline scale, GAIS).
- Standardise safety controls: Sterile workflow; single‑use fibres; temperature monitoring (<40°C); documented dosimetry; clear protocols for burns, infection and nerve symptoms.
- Select patients carefully: Avoid promising facelift‑level repositioning in severe laxity; consider surgical referral early.
- Integrate structure and envelope: Use jawline fillers strategically where volume loss drives contour collapse, then use tightening as an adjunct.
- Do not promote "laser dissolving" of HA filler: Manage HA filler issues with hyaluronidase and sequenced combination planning.
Evidence Gaps and Research Priorities
- Standardised parameter reporting (power, mode, total energy, fibre type, movement speed, treated area definition)
- Validated endpoints (Merz jawline scales, FACE‑Q, GAIS, 3D imaging, ultrasound, elastography)
- Independent safety registries capturing real‑world events
- Combination studies (subdermal laser + structural filler) with sequencing arms
References
- Longo, L., Dell'Avanzato, R. and Longo, D. (2022) 'ENDOLIFT® and multi‑wavelength laser photobiomodulation: a randomized controlled trial study on 96 subjects, treating skin laxity of the lower third of the face', Laser Therapy, 29(2), pp. 115–120.
- Nilforoushzadeh, M.A. et al. (2022) 'Endolift laser for jowl fat reduction: clinical evaluation and biometric measurement', Lasers in Medical Science, 37, pp. 2397–2401.
- Nilforoushzadeh, M.A. et al. (2024) 'The Endo‑lift Laser (Intralesional 1470 nm Diode Laser) for dermatological aesthetic conditions: a systematic review', Aesthetic Plastic Surgery, 48, pp. 5097–5114.
- Modena, D.A.O., de Melo Yamamoto, A.P. and da Silva, T.B.F. (2025) 'Endolift® is a non‑surgical treatment for skin tissue conditions. Is there evidence for its application?', Lasers in Medical Science, 40, Article 22.
- Borges, F.S. et al. (2023) 'Complications from laser Endolift use: case series and literature review', World Journal of Biology Pharmacy and Health Sciences, 16(03), pp. 023–041.
- Dias, L. et al. (2023) '1470 Nm diode laser effectiveness in facial fat reduction with the Endolifting technique: pilot study', International Journal of Medical Science and Clinical Invention, 10(6), pp. 6788–6795.
- Dallara, J‑M. et al. (2014) 'Calcium hydroxylapatite for jawline rejuvenation: consensus recommendations', Journal of Cosmetic Dermatology, 13, pp. 3–14.
- Wood, E. et al. (2024) 'Comparing the safety and effectiveness of microfocused ultrasound: standard vs targeted tissue protocol in lifting and tightening the lower face and upper neck', Journal of Drugs in Dermatology, 23(4), pp. 249–254.
- Nguyen, L. et al. (2022) 'Radiofrequency microneedling for skin tightening of the lower face, jawline, and neck region', Dermatologic Surgery.
- Borzabadi‑Farahani, A., Mosahebi, A. and Zargaran, D. (2024) 'A scoping review of hyaluronidase use in managing the complications of aesthetic interventions', Aesthetic Plastic Surgery, 48, pp. 1193–1209.
- Eufoton (2018) 'FTF system optical fibers' (product documentation).
- Eufoton (n.d.) 'LASEmaR® 1500' (product specifications).
- Mazzi, L. (2019) 'Face and neck lifting with Endolift technique using a 1470‑nm diode laser and a 300‑micron fibre', World Congress of Dermatology 2019 (conference abstract).
- Moradi, A. et al. (2023) 'Development and validation of a photonumeric scale for evaluation of jawline contour', Journal of Drugs in Dermatology, 22(2), pp. 203–209.